Economics of elective coronary revascularization. Comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery

Journal of the American College of Cardiology

Volumn 22, Issue 4, 1993, Pages 1052-1059

  Cohen, David J ^c   Breall, Jeffrey A ^c   Ho, Kalon K L ^c   Weintraub, Ronald M ^c   Kuntz, Richard E ^c   Weinstein, Milton C ^a,b   Baim, Donald S ^c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATHERECTOMY; BYPASS SURGERY; CORONARY ARTERY RECANALIZATION; COST EFFECTIVENESS ANALYSIS; FEMALE; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STENT;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATHERECTOMY, CORONARY; COMPARATIVE STUDY; CORONARY ARTERY BYPASS; CORONARY DISEASE; COST-BENEFIT ANALYSIS; FEES AND CHARGES; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HEART CATHETERIZATION; HUMAN; MALE; MIDDLE AGE; RETROSPECTIVE STUDIES; STENTS; SURGICAL PROCEDURES, ELECTIVE; TREATMENT OUTCOME;

EID: 0027359713     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(93)90415-W     Document Type: Article

References (34)

1. Percutaneous transluminal coronary angioplasty in 1985–1986 and 1977–1981: the National Heart, Lung, and Blood Institute Registry
2. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty: frequency, prediction, clinical course, management, and follow-up
3. Changing incidence and management of abrupt closure following coronary intervention in the new device era
4. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients
5. Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis
6. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty
7. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon
8. Medical approaches to prevention of restenosis after coronary angioplasty
9. Transluminal atherectomy for occlusive peripheral vascular disease
10. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty
11. Clinical experience with the Palmaz-Schatz coronary stent: initial results of a multicenter study
12. Intracoronary stenting during percutaneous transluminal coronary angioplasty
13. Long term results of directional coronary atherectomy predictors of restenosis
14. Angiographic and clinical outcome of intracoronary stenting: immediate and long-term results from a large single-center experience
15. Angiographic follow-up after placement of a self-expanding coronary-artery stent
16. Role of new technology in balloon angioplasty
17. In-hospital costs associated with new percutaneous coronary devices
18. Coronary-artery stents and other endoluminal devices
19. Stenting of coronary arteries has a modern Pandora's box been opened?
20. Intracoronary stenting—hope or hype?
21. The distinction between cost and charges
22. Resource use and cost of initial coronary revascularization. Coronary angioplasty versus coronary bypass surgery
23. Foundations of cost-effectiveness analysis for health and medical practices
24. Clinical economics: a guide to the economic analysis cf clinical practices
25. The cost of coronary bypass procedures
26. The variation in hospital charges: a problem in determining cost/benefit for cardiac surgery
27. Coronary atherectomy: clinical, angiographic, and histological findings and observations regarding potential mechanisms
28. Analysis of coronary angioplasty practice in the United States with an insurance-claims data base
29. Is percutaneous coronary angioplasty less expensive than bypass surgery?
30. Comparative cost of myocardial revascularization: percutaneous transluminal angioplasty and coronary artery bypass surgery
31. Comparative costs of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting in multivessel coronary artery disease
32. Comparison of costs of percutaneous transluminal coronary angioplasty and coronary bypass surgery for patients with angina pectoris
33. Relative cost of coronary angioplasty and bypass surgery in a one-vessel disease model